Mariska Leeflang
Impact in
- Infectious Diseases top 0.2%
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 detection and testing
- COVID-19 Clinical Research Studies
-
- Meta-analysis and systematic reviews
Papers in
-
- Meta-analysis and systematic reviews 56
- Reliability and Agreement in Measurement 23
- Co-authors
- Patrick M. BossuytJonathan J DeeksLotty HooftJohannes B. ReitsmaConstantine GatsonisYemisi TakwoingiRené SpijkerClare Davenport
- Journals
- Cochrane Database of Systematic Reviews (38 papers)Journal of Clinical Epidemiology (22 papers)Clinical Microbiology and Infection (9 papers)British Journal of Dermatology (5 papers)PLoS neglected tropical diseases (5 papers)
- Partner nations
- NetherlandsUnited KingdomCanada
In The Last Decade
Mariska Leeflang
190 papers receiving 11.4k citations
Hit Papers
Peers
Comparison fields: 5 of 190
- Infectious Diseases 2.9k
- Statistics, Probability and Uncertainty 857
- Health Informatics 146
- Immunology and Allergy 558
- Dermatology 756
Countries citing papers authored by Mariska Leeflang
This map shows the geographic impact of Mariska Leeflang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mariska Leeflang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mariska Leeflang more than expected).
Fields of papers citing papers by Mariska Leeflang
This network shows the impact of papers produced by Mariska Leeflang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mariska Leeflang. The network helps show where Mariska Leeflang may publish in the future.
Co-authors
The 25 scholars most cited alongside Mariska Leeflang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 9 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 5 | |
| 9 | 2022 | 7 | |
| 10 | 2021 | 22 | |
| 11 | 2021 | 7 | |
| 12 | 2021 | 15 | |
| 13 | 2020 | 26 | |
| 14 | 2020 | 27 | |
| 15 | 2020 | 4 | |
| 16 | 2019 | 21 | |
| 17 | 2016 | 14 | |
| 18 | A Novel Prognostic Model for Primary Sclerosing Cholangitis | 2015 | 0 |
| 19 | 2015 | 47 | |
| 20 | 2006 | 108 |
About Mariska Leeflang
Mariska Leeflang is a scholar working on Statistics, Probability and Uncertainty, Family Practice, Health Informatics, Infectious Diseases and Immunology and Allergy, having authored 197 papers that have together received 11.6k indexed citations. Recurring topics across this work include Meta-analysis and systematic reviews (56 papers), Reliability and Agreement in Measurement (23 papers), Health Systems, Economic Evaluations, Quality of Life (22 papers), SARS-CoV-2 detection and testing (14 papers), Statistical Methods in Clinical Trials (13 papers), COVID-19 Clinical Research Studies (11 papers), SARS-CoV-2 and COVID-19 Research (10 papers) and Dermatology and Skin Diseases (10 papers). The work is most often cited by research in Infectious Diseases (2.9k citations), Statistics, Probability and Uncertainty (857 citations), Health Informatics (146 citations), Immunology and Allergy (558 citations) and Dermatology (756 citations). Mariska Leeflang has collaborated with scholars based in Netherlands, United Kingdom and Canada. Frequent co-authors include Patrick M. Bossuyt, Jonathan J Deeks, Lotty Hooft, Johannes B. Reitsma, Constantine Gatsonis, Yemisi Takwoingi, René Spijker, Clare Davenport, Rob Scholten and Phyllis I. Spuls. Their work appears in journals such as Cochrane Database of Systematic Reviews, Journal of Clinical Epidemiology, Clinical Microbiology and Infection, British Journal of Dermatology and PLoS neglected tropical diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.